Charles E Linden

Charles E Linden ( CHARLES E LINDEN ) is A Dermatology Physician in Tarzana, CA. The NPI Number for Charles E Linden is 1508861634.

The current location address for Charles E Linden is 18364 CLARK ST Tarzana, CA 91356 and the contact number is 8183457122 and fax number is 8183457448. The mailing address for Charles E Linden is 18364 CLARK ST Tarzana, CA 91356- 8183457122 (mailing address contact number - 8183457122).

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

What is the NPI Number for Charles E Linden ?

Answer: The NPI Number for Charles E Linden is 1508861634

Where is Charles E Linden located?

Answer: Charles E Linden is located at 18364 CLARK ST Tarzana, CA 91356.

What is the specialty for Charles E Linden ?

Answer: The Specialty of Charles E Linden is A Dermatology Physician.

Are there any online reviews for Charles E Linden ?

Answer: Yes! Check It Now.

Are there any other health care providers in Tarzana, CA?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Charles E Linden

Number of HCPCS	48
Number of Medicare Beneficiaries	816
Number of Services	5912
Total Submitted Charge Amount	471710
Total Medicare Allowed Amount	348571.04
Total Medicare Payment Amount	255871.59
Total Medicare Standardized Payment Amount	232615.62
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services	3
Number of Medicare Beneficiaries With Drug Services	13
Number of Drug Services	50
Total Drug Submitted Charge Amount	5215
Total Drug Medicare Allowed Amount	3950.44
Total Drug Medicare Payment Amount	3160.31
Total Drug Medicare Standardized Payment Amount	3097.1
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services	45
Number of Medicare Beneficiaries With Medical	816
Number of Medical Services	5862
Total Medical Submitted Charge Amount	466495
Total Medical Medicare Allowed Amount	344620.6
Total Medical Medicare Payment Amount	252711.28
Total Medical Medicare Standardized Payment Amount	229518.52
Average Age of Beneficiaries	77
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74	327
Number of Beneficiaries Age 75 to 84	334
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries	364
Number of Male Beneficiaries	452
Number of Non-Hispanic White Beneficiaries	763
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries	17
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified	21
Number of Beneficiaries With Medicare & Medicaid Entitlement
Number of Beneficiaries With Medicare Only Entitlement
Percent (%) of Beneficiaries Identified With Atrial Fibrillation	0.11
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia	0.07
Percent (%) of Beneficiaries Identified With Asthma	0.05
Percent (%) of Beneficiaries Identified With Cancer	0.16
Percent (%) of Beneficiaries Identified With Heart Failure	0.11
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease	0.26
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease	0.06
Percent (%) of Beneficiaries Identified With Depression	0.13
Percent (%) of Beneficiaries Identified With Diabetes	0.26
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.68
Percent (%) of Beneficiaries Identified With Hypertension	0.63
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.38
Percent (%) of Beneficiaries Identified With Osteoporosis	0.13
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.45
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke	0.04
Average HCC Risk Score of Beneficiaries	0.9683

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Dermatology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	347
Number of Standardized 30-Day Fills	415.66666667
Aggregate Cost Paid for All Claims	65260.08
Number of Day's Supply for All Claims	10812
Number of Medicare Beneficiaries	159
Number of Claims, Including Refills, for Beneficiaries Age 65+	347
Including Refills, for Beneficiaries Age 65+	415.66666667
Beneficiaries Age 65+	65260.08
Number of Day's Supply for All Claims for Beneficaries Age 65+	10812
Number of Medicare Beneficiaries Age 65+	159
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	26
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	321
Aggregate Cost Paid for Generic Drugs	11645.04
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst	*
Number of Claims for Beneficiaries Covered by MAPD Plans
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst	#
Number of Claims for Beneficiaries Covered by Standalone PDP Plans
Aggregate Cost Paid for Claims Filled by
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst	*
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst	#
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	30
Aggregate Cost Paid for Antibiotic Drugs	992.75
Antibiotic Claims	12
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims	0
Average Age of Beneficiaries	78.698113208
Number of Beneficiaries Age Less Than 65	0
Number of Beneficiaries Age 65 to 74	57
Number of Beneficiaries Age 75 to 84	63
Number of Female Beneficiaries	70
Number of Male Beneficiaries	89
Number of Non-Hispanic White	146
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.1022012579